Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand

被引：0
|
作者：
Chunhuan Lao
Marion Kuper-Hommel
Mark Elwood
Ian Campbell
Melissa Edwards
Ross Lawrenson
机构：
[1] The University of Waikato,Waikato Medical Research Centre
[2] Waikato District Health Board,Medical Oncology
[3] The University of Auckland,School of Population Health
[4] The University of Auckland,School of Medicine
[5] Waikato District Health Board,General Surgery
[6] Waikato District Health Board,Strategy and Funding
来源：
Breast Cancer | 2021年 / 28卷
关键词：
De novo metastatic breast cancer; Recurrent metastatic breast cancer; Survival; Biomarker subtype; Metastatic-free interval; Site of metastases;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：387 / 397
页数：10
相关论文
共 50 条
  • [1] Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand
    Lao, Chunhuan
    Kuper-Hommel, Marion
    Elwood, Mark
    Campbell, Ian
    Edwards, Melissa
    Lawrenson, Ross
    BREAST CANCER, 2021, 28 (02) : 387 - 397
  • [2] Survival in Young Women with De Novo or Recurrent Metastatic Breast Cancer
    Varella, Leticia
    Zheng, Yue
    Rosenberg, Shoshana
    Kirkner, Gregory
    Snow, Craig
    Ruddy, Kathryn
    Tamimi, Rulla
    Peppercorn, Jeffrey
    Schapira, Lidia
    Borges, Virginia
    Come, Steven
    Collins, Laura
    Warner, Ellen
    Dibble, Kate
    Winer, Eric
    Partridge, Ann
    CANCER RESEARCH, 2024, 84 (09)
  • [3] Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients
    McKenzie, Hayley S.
    Maishman, Tom
    Simmonds, Peter
    Durcan, Lorraine
    Eccles, Diana
    Copson, Ellen
    BRITISH JOURNAL OF CANCER, 2020, 122 (11) : 1618 - 1629
  • [4] Survival and disease characteristics of de novo versus recurrent metastatic breast cancer in a cohort of young patients
    Hayley S. McKenzie
    Tom Maishman
    Peter Simmonds
    Lorraine Durcan
    Diana Eccles
    Ellen Copson
    British Journal of Cancer, 2020, 122 : 1618 - 1629
  • [5] Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer
    Danielle M. File
    Tomas Pascual
    Allison M. Deal
    Amy Wheless
    Charles M. Perou
    E. Claire Dees
    Lisa A. Carey
    Breast Cancer Research and Treatment, 2022, 196 : 153 - 162
  • [6] Clinical Characteristics and Survival Outcomes of Patients with De Novo Metastatic Breast Cancer
    Almasri, Hanan
    Erjan, Ayah
    Abudawaba, Hebah
    Ashouri, Khaled
    Mheid, Sara
    Alnsour, Anoud
    Abdel-Razeq, Hikmat
    BREAST CANCER-TARGETS AND THERAPY, 2022, 14 : 363 - 373
  • [7] Clinical subtype, treatment response, and survival in De Novo and recurrent metastatic breast cancer
    File, Danielle M.
    Pascual, Tomas
    Deal, Allison M.
    Wheless, Amy
    Perou, Charles M.
    Dees, E. Claire
    Carey, Lisa A.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 196 (01) : 153 - 162
  • [8] Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer
    Barcenas, Carlos H.
    Song, Juhee
    Murthy, Rashmi K.
    Raghavendra, Akshara S.
    Li, Yisheng
    Hsu, Limin
    Carlson, Robert W.
    Tripathy, Debu
    Hortobagyi, Gabriel N.
    JCO CLINICAL CANCER INFORMATICS, 2021, 5 : 789 - 804
  • [9] METASTATIC BREAST CANCER: PROGNOSTIC FACTORS OF SURVIVAL AND THE DIFFERENCE BETWEEN DE NOVO AND RECURRENT DISEASE
    Rommel, Kim
    Ettl, Johannes
    Kiechle, Marion
    Bronger, Holger
    ANTICANCER RESEARCH, 2023, 43 (07) : 3375 - 3375
  • [10] Prognosis of metastatic breast cancer: are there differences between patients with de novo and recurrent metastatic breast cancer?
    D J A Lobbezoo
    R J W van Kampen
    A C Voogd
    M W Dercksen
    F van den Berkmortel
    T J Smilde
    A J van de Wouw
    F P J Peters
    J M G H van Riel
    N A J B Peters
    M de Boer
    P G M Peer
    V C G Tjan-Heijnen
    British Journal of Cancer, 2015, 112 : 1445 - 1451
12345